Implantable cardioverter-defibrillators are preferable to drugs as primary therapy in sustained ventricular tachyarrhythmias
- 30 June 1996
- journal article
- review article
- Published by Elsevier in Progress in Cardiovascular Diseases
- Vol. 38 (6), 445-454
- https://doi.org/10.1016/s0033-0620(96)80008-9
Abstract
No abstract availableKeywords
This publication has 44 references indexed in Scilit:
- Evaluating and improving the cost-effectiveness of the implantable cardioverter—defibrillatorAmerican Heart Journal, 1995
- Antiarrhythmics Versus Implantable Defibrillators (AVID)—Rationale, design, and methodsThe American Journal of Cardiology, 1995
- The role of implantable cardioverter defibrillators in dilated cardiomyopathyAmerican Heart Journal, 1994
- Implantable cardioverter defibrillator compared with antiarrhythmic drug treatment in cardiac arrest survivors (the Cardiac Arrest Study Hamburg)American Heart Journal, 1994
- Stratification of sudden death risk in patients receiving long-term amiodarone treatment for sustained ventricular tachycardia or ventricular fibrillationThe American Journal of Cardiology, 1993
- Survival after implantation of the cardioverter defibrillatorThe American Journal of Cardiology, 1992
- Cardiac arrest in seattle: Conventional versus amiodarone drug evaluation (the CASCADE study)The American Journal of Cardiology, 1991
- Beta blockade during and after myocardial infarction: An overview of the randomized trialsProgress in Cardiovascular Diseases, 1985
- Management of recurrent ventricular tachycardia: Economic impact of therapeutic alternativesThe American Journal of Cardiology, 1984
- Endocardial excision: a new surgical technique for the treatment of recurrent ventricular tachycardia.Circulation, 1979